Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution
27 Novembre 2023 - 2:30PM
Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the
“Company”), a medical technology company delivering intelligent,
rapid, non-invasive testing solutions, today announced that
successful Australian civil construction entity, State Road
Constructions ("State Road"), has selected its proprietary
Intelligent Fingerprinting Drug Screening System as its workplace
drug screening solution.
State Road Constructions supplies earthmoving
equipment and heavy vehicle hire to large infrastructure and civil
development projects across New South Wales with notable works,
including Sydney’s Light Rail and Rozelle Interchange projects. The
company will implement INBS’ drug screening solution to continue
meeting internal health and safety requirements and ensure
compliance with policy. The system’s rapid functionality was a key
feature for State Road, aligning with the company’s dedication to
operational efficiency.
INBS’ Intelligent Fingerprinting Drug Screening
System differs from traditional tests commonly used in the
construction industry, such as urine and saliva. It offers a
non-invasive solution and dignified collection method that uses
fingertip sweat to screen for major drugs of abuse. The system’s
14-16 hour detection window focuses on fitness for duty on the day
of testing, upholding employee privacy while maintaining a safe and
respectful workplace for all. Businesses can efficiently collect
samples and reduce costs by detecting cannabis (THC), cocaine,
methamphetamines, and opiates in minutes without the need for
specialist staff or facilities.
Harry Simeonidis, President and Chief Executive
Officer at Intelligent Bio Solutions, said, "State Road
Construction's adoption of our solution is an example of
organizational progression toward more dignified practices and
complete solutions that respect all individuals while at the same
time enhancing workplace safety and efficiency. Employing our
system means State Road Constructions can maintain safety while
ensuring its projects comply with testing mandates. We look forward
to growing the business relationship and ensuring State Road has
the best outcomes using our non-invasive, efficient drug screening
solution."
The system’s portability makes it easy to deploy
onsite, and employers in safety-critical industries such as
construction can create and maintain cost-effective drug testing
solutions that meet requirements in random, pre-employment, and
post-accident drug testing.
View INBS' Intelligent Fingerprinting Drug
Screening System video to learn more about its simple, dignified
approach to testing.
About State Road
Constructions
State Road Constructions is a civil construction
company that supplies earthmoving equipment and heavy vehicle
haulage to large infrastructure and civil development projects.
Since its establishment in 2012, State Road Constructions has held
multiple notable contracts for large infrastructure and civil
developments throughout New South Wales. The company’s director has
over 15 years of experience contributing high-quality services to
Government projects and large commercial developments. State Road
Constructions is an industry-leading civil construction company
that offers reliable, on-time solutions for long-term and
short-term projects. The company specializes in haulage, material
disposal, plant hire and onsite works.
To learn more, visit:
https://www.stateroadconstructions.com.au/.
About Intelligent Bio Solutions Inc.
(NADAQ: INBS)
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is
a medical technology company delivering innovative, rapid,
non-invasive testing solutions. The Company believes that its
Intelligent Fingerprinting Drug Screening System will revolutionize
portable testing through fingerprint sweat analysis, which has the
potential for broader applications in additional fields. Designed
as a hygienic and cost-effective system, the test screens for
recent use of drugs commonly found in the workplace, including
opioids, cocaine, methamphetamine, and cannabis. With sample
collection in seconds and results in under ten minutes, this
technology would be a valuable tool for employers in
safety-critical industries. Additionally, the Company's biosensor
platform has the potential to test for up to 130 indications,
ranging from glucose to immunological conditions and communicable
diseases. The Company's current customer segments include
construction, manufacturing and engineering, transport and
logistics firms, drug treatment organizations, and coroners.
To learn more, visit: https://ibs.inc/.
Forward-Looking Statements
Some of the statements in this press release are
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act
of 1934, and the Private Securities Litigation Reform Act of 1995,
which involve risks and uncertainties. Forward-looking statements
in this press release include, without limitation, Intelligent Bio
Solutions Inc.'s ability to successfully develop and commercialize
its drug and diagnostic tests, realize commercial benefit from its
partnerships and collaborations, and secure regulatory approvals.
Although Intelligent Bio Solutions Inc. believes that the
expectations reflected in such forward-looking statements are
reasonable as of the date made, expectations may prove to have been
materially different from the results expressed or implied by such
forward-looking statements. Intelligent Bio Solutions Inc. has
attempted to identify forward-looking statements by terminology,
including" believes,"" estimates,"" anticipates,"" expects,""
plans,"" projects,"" intends,"" potential,"" may,"" could,""
might,"" will,"" should,"" approximately" or other words that
convey uncertainty of future events or outcomes to identify these
forward-looking statements. These statements are only predictions
and involve known and unknown risks, uncertainties, and other
factors, included in Intelligent Bio Solutions' public filings
filed with the Securities and Exchange Commission. Any
forward-looking statements contained in this release speak only as
of its date. Intelligent Bio Solutions undertakes no obligation to
update any forward-looking statements contained in this release to
reflect events or circumstances occurring after its date or to
reflect the occurrence of unanticipated events.
Company Contact:
Intelligent Bio Solutions Inc.New York Office:
#646-790-5756info@ibs.inc
Investor Relations:Valter
Pinto, Managing DirectorKCSA Strategic Communications#(212)
896-1254INBS@kcsa.com
Media Contact: Cheryl Billson
Comma Communications cheryl.billson@commacomms.com
Grafico Azioni Intelligent Bio Solutions (NASDAQ:INBS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Intelligent Bio Solutions (NASDAQ:INBS)
Storico
Da Giu 2023 a Giu 2024